BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 188737)

  • 21. [Hyperparathyroid-like syndrome associated with hepatoma].
    Kaplinsky N; Cohen S; Fraenkel O
    Harefuah; 1972 Dec; 83(11):479-80. PubMed ID: 4360851
    [No Abstract]   [Full Text] [Related]  

  • 22. Changing patterns of hepatocellular carcinoma.
    Choudhary AM; Roberts I; Gupta T
    Am J Gastroenterol; 1999 Sep; 94(9):2571-2. PubMed ID: 10484035
    [No Abstract]   [Full Text] [Related]  

  • 23. Decreased disappearance rate of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) from the blood and its unresponsiveness to tocophreyl nicotinate and indomethacin in patients with primary hepatocellular carcinoma.
    Hobara N; Watanabe A
    Acta Med Okayama; 1979 Oct; 33(5):389-93. PubMed ID: 229696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low serum testosterone: a special feature of hepatocellular carcinoma.
    Lampropoulou-Karatzas C; Goritsas P; Makri MG
    Eur J Med; 1993 Jan; 2(1):23-7. PubMed ID: 8258001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some haematological observations of Kenyan hepatocellular carcinoma (HCC) patients.
    Mukiibi JM; Mwaungulu GS; Wankya BM
    East Afr Med J; 1982 Feb; 59(2):118-26. PubMed ID: 6290180
    [No Abstract]   [Full Text] [Related]  

  • 26. [Malignant humoral hypercalcemia complicating hepatocellular carcinoma and rectal adenocarcinoma].
    Béchade D; Algayres JP; Texier F; Bili H; Mennecier D; Hélie C
    Presse Med; 2000 Dec; 29(38):2096. PubMed ID: 11147049
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma.
    Doğan UB; Cindoruk M; Dumlu S; Unlü R; Unal S
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):476-7. PubMed ID: 9494860
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatocellular carcinoma with hepatitis C antibody positivity in a male with porphyria cutanea tarda].
    Santos Vicente J; Suriñach Caralt JM; Blanch P; Mirada Canals A
    Med Clin (Barc); 1992 Apr; 98(14):558. PubMed ID: 1318481
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemochromatosis, hepatoma, erythrocytosis, and erythropoietin.
    Lizzi FA; Tartaglia AP; Adamson JW
    N Y State J Med; 1973 May; 73(9):1098-100. PubMed ID: 4348807
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation].
    Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
    Bull Cancer; 1984; 71(5):442-5. PubMed ID: 6084528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis.
    Chan KK; Chlebowski RT; Tong M; Chen HS; Gross JF; Bateman JR
    Cancer Res; 1980 Apr; 40(4):1263-8. PubMed ID: 6244090
    [No Abstract]   [Full Text] [Related]  

  • 32. [Iron-deficiency anemia of unknown origin with blood ferritin as a presenting form of hepatocarcinoma without cirrhosis].
    Villalta J; Pujol A; Ramírez J; Lens XM; Ingelmo M; Balcells A
    Rev Clin Esp; 1984 Jan; 172(2):117-8. PubMed ID: 6326206
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraneoplastic syndromes in primary liver cell carcinoma in Nigeria.
    Teniola SO; Ogunleye IO
    Trop Geogr Med; 1994; 46(1):20-2. PubMed ID: 8165731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercalcemia in thyrotoxicosis.
    Maxon HR; Apple DJ; Goldsmith RE
    Surg Gynecol Obstet; 1978 Nov; 147(5):694-6. PubMed ID: 715646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fibrolamellar hepatocellular carcinoma: a clinical report with paraneoplastic hyperthyroidism (apropos of a case)].
    Carri J; Peral F; Surreco M; Luján A; Leguizamón R; Martínez G; Salvucci M
    Acta Gastroenterol Latinoam; 1989; 19(3):155-64. PubMed ID: 2561432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum levels of osteocalcin in hypercalcemia caused by primary hyperparathyroidism and in tumor hypercalcemia].
    de la Piedra C; Rapado A; Esbrit P
    Rev Clin Esp; 1985 Nov; 177(7):310-3. PubMed ID: 3878548
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypercalcemic encephalopathy in a patient with hepatocellular carcinoma.
    Tudela P; Soldevila B; Mòdol JM; Domènech E
    Dig Dis Sci; 2007 Nov; 52(11):3296-7. PubMed ID: 17429730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Small cell ovarian carcinoma with hypercalcemia: the role of the parathyroid hormone].
    Bertoni F; Ferramosca B; Bacchini P
    G Clin Med; 1983 Dec; 64(12):564-70. PubMed ID: 6323241
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.